• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有肥厚型心肌病并植入了除颤器的生活。

Living with hypertrophic cardiomyopathy and an implantable defibrillator.

作者信息

Magnusson Peter, Jonsson Jessica, Mörner Stellan, Fredriksson Lennart

机构信息

Cardiology Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital/Solna, SE-171 76, Stockholm, Sweden.

Centre for Research and Development, Uppsala University/Region Gävleborg, SE-801 87, Gävle, Sweden.

出版信息

BMC Cardiovasc Disord. 2017 May 10;17(1):121. doi: 10.1186/s12872-017-0553-y.

DOI:10.1186/s12872-017-0553-y
PMID:28490380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5424404/
Abstract

BACKGROUND

ICDs efficiently terminate life-threatening arrhythmias, but complications occur during long-term follow-up. Patients' own perspective is largely unknown. The aim of the study was to describe experiences of hypertrophic cardiomyopathy (HCM) patients with implantable defibrillators (ICDs).

METHODS

We analyzed 26 Swedish patient interviews using hermeneutics and latent content analysis.

RESULTS

Patients (aged 27-76 years) were limited by HCM especially if it deteriorates into heart failure. The ICD implies safety, gratitude, and is accepted as a part of the body even when inappropriate ICD shocks are encountered. Nobody regretted the implant. Both the disease and the ICD affected professional life and leisure time activities, especially at younger ages. Family support was usually strong, but sometimes resulted in overprotection, whereas health care focused on medical issues. Despite limitations, patients adapted, accepted, and managed challenges.

CONCLUSION

HCM patients with ICDs reported good spirit and hope even though they had to adapt and accept limitations over time.

摘要

背景

植入式心律转复除颤器(ICD)能有效终止危及生命的心律失常,但在长期随访过程中会出现并发症。患者自身的看法在很大程度上尚不明确。本研究的目的是描述肥厚型心肌病(HCM)患者使用植入式除颤器(ICD)的体验。

方法

我们采用诠释学和潜在内容分析法对26名瑞典患者的访谈进行了分析。

结果

患者(年龄在27至76岁之间)受到肥厚型心肌病的限制,尤其是当病情恶化为心力衰竭时。ICD意味着安全、感恩,即使遇到不适当的ICD电击,患者也会将其视为身体的一部分而接受。没有人后悔植入ICD。疾病和ICD都对职业生活和休闲活动产生了影响,尤其是在年轻时。家庭支持通常很强大,但有时会导致过度保护,而医疗保健则侧重于医疗问题。尽管存在限制,患者还是适应、接受并应对了挑战。

结论

植入ICD的肥厚型心肌病患者报告称,尽管随着时间的推移他们不得不适应并接受各种限制,但他们仍保持着良好的精神状态和希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaf/5424404/261cbe05644b/12872_2017_553_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaf/5424404/261cbe05644b/12872_2017_553_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfaf/5424404/261cbe05644b/12872_2017_553_Fig1_HTML.jpg

相似文献

1
Living with hypertrophic cardiomyopathy and an implantable defibrillator.患有肥厚型心肌病并植入了除颤器的生活。
BMC Cardiovasc Disord. 2017 May 10;17(1):121. doi: 10.1186/s12872-017-0553-y.
2
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.肥厚型心肌病和植入式心脏复律除颤器高危患者的临床过程和生活质量。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.
3
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.肥厚型心肌病患者皮下植入式心律转复除颤器:初步经验
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
4
Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.肥厚型心肌病患者的植入式心脏复律除颤器:长期随访中的疗效和治疗并发症。
J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):883-9. doi: 10.1111/j.1540-8167.2009.01716.x. Epub 2010 Feb 1.
5
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.基于模板心电图筛查肥厚型心肌病患者皮下植入式心脏复律除颤器候选者的患病率。
Heart Rhythm. 2016 Feb;13(2):457-63. doi: 10.1016/j.hrthm.2015.09.007. Epub 2015 Sep 8.
6
Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.来自EFFORTLESS和IDE队列汇总数据的肥厚型心肌病皮下植入式心律转复除颤器早期性能评估。
Heart Rhythm. 2016 May;13(5):1066-1074. doi: 10.1016/j.hrthm.2016.01.001. Epub 2016 Jan 6.
7
Patient understanding of disease and the use and outcome of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.肥厚型心肌病患者对疾病的理解以及植入式心律转复除颤器的使用与疗效
Pacing Clin Electrophysiol. 2018 Jan;41(1):57-64. doi: 10.1111/pace.13234. Epub 2017 Dec 28.
8
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.肥厚型心肌病中使用植入式除颤器进行风险分层和预防猝死的当代策略。
Heart Rhythm. 2016 May;13(5):1155-1165. doi: 10.1016/j.hrthm.2015.12.048. Epub 2016 Jan 1.
9
Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.瑞典的肥厚型心肌病与植入式除颤器:不适当电击及需要手术的并发症
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1088-94. doi: 10.1111/jce.12750. Epub 2015 Sep 2.
10
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.植入型心律转复除颤器治疗肥厚型心肌病的疗效和并发症:系统评价和荟萃分析。
Circ Heart Fail. 2012 Sep 1;5(5):552-9. doi: 10.1161/CIRCHEARTFAILURE.112.969626. Epub 2012 Jul 20.

引用本文的文献

1
Knowledge, attitude, and practice toward hypertrophic cardiomyopathy of patients with primary hypertension: a cross-sectional study.原发性高血压患者对肥厚型心肌病的认知、态度和行为:一项横断面研究。
Sci Rep. 2025 Aug 30;15(1):31984. doi: 10.1038/s41598-025-17759-8.
2
Qualitative analysis of experiences, burdens, and needs among patients with hypertrophic cardiomyopathy in Japan.日本肥厚型心肌病患者的经历、负担和需求的定性分析
Future Cardiol. 2025 Aug;21(10):759-768. doi: 10.1080/14796678.2025.2526279. Epub 2025 Jul 11.
3
Current Knowledge of Hypertrophic Cardiomyopathy Among Health Care Providers in Sweden.

本文引用的文献

1
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy.肥厚型心肌病晚期心力衰竭的临床谱、治疗选择及预后
Circ Heart Fail. 2015 Nov;8(6):1014-21. doi: 10.1161/CIRCHEARTFAILURE.114.001843. Epub 2015 Oct 7.
2
Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.瑞典的肥厚型心肌病与植入式除颤器:不适当电击及需要手术的并发症
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1088-94. doi: 10.1111/jce.12750. Epub 2015 Sep 2.
3
New perspectives on the prevalence of hypertrophic cardiomyopathy.
瑞典医疗保健人员对肥厚型心肌病的当前认知
Cureus. 2020 Dec 22;12(12):e12220. doi: 10.7759/cureus.12220.
4
Shock to the Heart: Psychosocial Implications and Applications of Sudden Cardiac Death in the Young.心脏震惊:青年心源性猝死的心理社会影响及其应用。
Curr Cardiol Rep. 2020 Oct 10;22(12):168. doi: 10.1007/s11886-020-01419-6.
5
Decision regret in implantable cardioverter-defibrillator recipients : A cross-sectional analysis on patients that regret their decision after ICD implantation.植入式心脏复律除颤器接受者的决策后悔:对植入ICD后对其决策感到后悔的患者的横断面分析。
Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):77-83. doi: 10.1007/s00399-020-00675-x. Epub 2020 Feb 20.
肥厚型心肌病患病率的新视角。
J Am Coll Cardiol. 2015 Mar 31;65(12):1249-1254. doi: 10.1016/j.jacc.2015.01.019.
4
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.瑞典植入式电子设备的使用现状:来自瑞典起搏器和植入式心脏复律除颤器注册中心的数据。
Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21.
5
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
6
Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中左心室不良重塑对心源性猝死的影响。
Clin Cardiol. 2014 Aug;37(8):493-8. doi: 10.1002/clc.22293. Epub 2014 Jul 4.
7
Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.配偶对植入式心脏复律除颤器治疗的思考,重点关注未来和生命终结:一项定性内容分析
J Adv Nurs. 2014 Aug;70(8):1758-69. doi: 10.1111/jan.12330. Epub 2013 Dec 9.
8
Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients' requests for treatment.植入式心脏复律除颤器患者的焦虑症:发生率、病程、预测因素及患者的治疗需求
Pacing Clin Electrophysiol. 2014 Jan;37(1):35-47. doi: 10.1111/pace.12276. Epub 2013 Sep 19.
9
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.植入式心脏复律除颤器在肥厚型心肌病中的应用:患者结局、恰当和不恰当干预的发生率以及并发症。
Am Heart J. 2013 Sep;166(3):496-502. doi: 10.1016/j.ahj.2013.06.009. Epub 2013 Jul 16.
10
Living with hypertrophic cardiomyopathy.肥厚型心肌病的生活。
J Nurs Scholarsh. 2013 Dec;45(4):371-9. doi: 10.1111/jnu.12040. Epub 2013 Jul 1.